Meridian Bioscience Debt 2024

Meridian Bioscience Aktienanalyse

What does Meridian Bioscience do?

Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Meridian Bioscience's Debt Structure

Meridian Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Meridian Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Meridian Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Meridian Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Meridian Bioscience Stock

What is the debt of Meridian Bioscience this year?

Meridian Bioscience has a debt level of -56.45 USD this year.

What was the debt of Meridian Bioscience compared to the previous year?

The debt of Meridian Bioscience has increased by -651.89% compared to the previous year dropped.

What are the consequences of high debt for investors in Meridian Bioscience?

High debt can pose a risk for investors of Meridian Bioscience, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Meridian Bioscience?

Low debt means that Meridian Bioscience has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Meridian Bioscience affect the company?

An increase in debt of Meridian Bioscience can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Meridian Bioscience affect the company?

A reduction in debt of Meridian Bioscience can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Meridian Bioscience?

Some factors that can influence the debt of Meridian Bioscience include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Meridian Bioscience so important for investors?

The debts of Meridian Bioscience are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Meridian Bioscience take to change the debt?

To change the debt, Meridian Bioscience can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Meridian Bioscience pay?

Over the past 12 months, Meridian Bioscience paid a dividend of 0.13 USD . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Meridian Bioscience is expected to pay a dividend of 0.51 USD.

What is the dividend yield of Meridian Bioscience?

The current dividend yield of Meridian Bioscience is 0.37 %.

When does Meridian Bioscience pay dividends?

Meridian Bioscience pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Meridian Bioscience?

Meridian Bioscience paid dividends every year for the past 3 years.

What is the dividend of Meridian Bioscience?

For the upcoming 12 months, dividends amounting to 0.51 USD are expected. This corresponds to a dividend yield of 1.51 %.

In which sector is Meridian Bioscience located?

Meridian Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Meridian Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meridian Bioscience from 2/14/2019 amounting to 0.125 USD, you needed to have the stock in your portfolio before the ex-date on 2/1/2019.

When did Meridian Bioscience pay the last dividend?

The last dividend was paid out on 2/14/2019.

What was the dividend of Meridian Bioscience in the year 2023?

In the year 2023, Meridian Bioscience distributed 0 USD as dividends.

In which currency does Meridian Bioscience pay out the dividend?

The dividends of Meridian Bioscience are distributed in USD.